Search results
VBI Vaccine (VBIV) Inks Deal With Agenus for Brain Cancer Study
Zacks via Yahoo Finance· 2 years agoVBI Vaccines (VBIV) enters into a partnership with Agenus to conduct a study evaluating the former's...
VBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plans
Zacks via Yahoo Finance· 1 year agoVBI Vaccines (VBIV) will focus on its HBV vaccine product and advancing its HBV immunotherapeutic...
What Type Of Shareholders Own The Most Number of VBI Vaccines Inc. (NASDAQ:VBIV) Shares?
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in VBI Vaccines Inc. (NASDAQ:VBIV) should be aware of the most powerful shareholder...
VBI Vaccines, Inc. (VBIV) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoVBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of -157.14% and 50.78%,...
VBI Vaccines Announces Cost Cutting Measures, Reverse Stock Split
Benzinga via Yahoo Finance· 1 year agoVBI Vaccines Inc (NASDAQ: VBIV) plans to focus concentrating on broadening access to VBI's...
VBI Vaccines, Inc. (VBIV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks via Yahoo Finance· 1 year agoVBI Vaccines, Inc. (VBIV) doesn't possess the right combination of the two key ingredients for a...
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
Benzinga via Yahoo Finance· 2 years agoVBI Vaccines Inc (NASDAQ: VBIV) and Agenus Inc (NASDAQ: AGEN) collaborated to evaluate a combination...
VBI Vaccines Inc.'s (NASDAQ:VBIV) Intrinsic Value Is Potentially 30% Above Its Share Price
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights The projected fair value for VBI Vaccines is US$3.70 based on 2 Stage Free Cash Flow to...
VBI Vaccines Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 1 year agoVBI Vaccines (NASDAQ:VBIV) Full Year 2022 Results Key Financial Results Net loss: US$113.3m (loss...
Strategic Licensing Agreements: Brii Bio’s Expansion into Chronic Disease Treatments with VBI...
Exec Edge via Yahoo Finance· 4 months agoBy Daniella Parra Brii Biosciences and VBI Vaccines (NASDAQ: VBIV) said they will expand and control...